Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2019
August 12, 2019 at 07:02 pm EDT
Share
Sinphar Pharmaceutical Co.,Ltd. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was TWD 572.514 million compared to TWD 529.340 million a year ago. Operating loss was TWD 68.363 million compared to TWD 37.246 million a year ago. Net loss was TWD 24.917 million compared to TWD 1.324 million a year ago. Basic loss per share was TWD 0.15 compared to TWD 0.01 a year ago. For the half year, sales was TWD 1,145.387 million compared to TWD 1,089.466 million a year ago. Operating loss was TWD 88.146 million compared to TWD 40.892 million a year ago. Net loss was TWD 10.625 million compared to net income of TWD 15.429 million a year ago. Basic loss per share was TWD 0.06 compared to basic earnings per share of TWD 0.09 a year ago.
Sinphar Pharmaceutical Co., Ltd. is principally engaged in the research and development, manufacture and distribution of pharmaceuticals. The Company is also engaged in the sales of functional food products. The Companyâs principal products include ointment, gel, cream, hard and soft capsules, sugar-coated tablets, film-coated tablets, suppositories, powders and granules, lozenges, soft candies, oral and topical liquid medicines, injections, dry medicated powers, functional food products, medical equipment and cosmetics. The Company mainly sells its products to hospitals, drug stores, clinics, dealers and distributors. Its primary markets are located in Taiwan and overseas countries.
SINPHAR PHARMACEUTICAL CO.,LTD. 
